These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8005919)

  • 1. Newer hypoglycaemic agents-its relevance.
    Shah SN; Ajmera J
    J Assoc Physicians India; 1993 Nov; 41(11):699. PubMed ID: 8005919
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification in sucrose tolerance test with acarbose, guargum and their combination in patients with non-insulin dependent diabetes.
    Shah PK; Lakhotia M; Purohit A; Jain SK; Gupta SK; Bhandari P
    J Assoc Physicians India; 1993 Nov; 41(11):703-5. PubMed ID: 8005921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of intestinal alpha glucosidases in the therapy of diabetes mellitus].
    Fölsch UR; Lembcke B
    Internist (Berl); 1991 Dec; 32(12):699-707. PubMed ID: 1823561
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin, glibenclamide plus acarbose in diabetes mellitus?].
    Hauner H
    Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044
    [No Abstract]   [Full Text] [Related]  

  • 5. [New, in Austria registered specialty drugs. Glucobay (acarbose)].
    Sturm M
    Wien Klin Wochenschr; 1992; 104(11):329-36. PubMed ID: 1621396
    [No Abstract]   [Full Text] [Related]  

  • 6. New horizons in diabetes therapy--alpha glucosidase inhibitors.
    Jawad F
    J Pak Med Assoc; 1994 Mar; 44(3):59-60. PubMed ID: 8040998
    [No Abstract]   [Full Text] [Related]  

  • 7. Acarbose, an alpha-glucosidase inhibitor for non-insulin-dependent diabetes.
    Welborn TA
    Med J Aust; 1998 Jan; 168(2):76-8. PubMed ID: 9469188
    [No Abstract]   [Full Text] [Related]  

  • 8. Acarbose for diabetes mellitus.
    Med Lett Drugs Ther; 1996 Feb; 38(967):9-10. PubMed ID: 8559114
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in the treatment of type II diabetes mellitus.
    Baliga BS; Fonseca VA
    Am Fam Physician; 1997 Feb; 55(3):817-24. PubMed ID: 9048504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with acarbose as first line therapy in NIDDM.
    Fölsch UR
    Clin Invest Med; 1995 Aug; 18(4):312-7. PubMed ID: 8549018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy in adult-onset diabetes].
    Groop L; Uusitupa M
    Duodecim; 1990; 106(9):759-65. PubMed ID: 1670368
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing therapy and adverse effects with antihyperglycemic agents: a focus on metformin and acarbose.
    Phillips BB
    Pharm Pract Manag Q; 1997 Oct; 17(3):21-31. PubMed ID: 10173308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acarbose: can it take a bite out of type 2 diabetes mellitus?
    Ponte CD
    Ann Pharmacother; 1996 Nov; 30(11):1333-5. PubMed ID: 8913419
    [No Abstract]   [Full Text] [Related]  

  • 14. [The use of guar gum in treating hypercholesterolemia].
    Uusitupa M
    Ter Arkh; 1991; 63(8):70-2. PubMed ID: 1665249
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of acarbose in the treatment of diabetes mellitus].
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):385-90. PubMed ID: 9805654
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acarbose in the treatment of type 2 diabetes].
    Amoretti R; Cicconetti C; De Nichilo M; Teodonio C; Fasani R; Carosi M
    Minerva Dietol Gastroenterol; 1986; 32(1):53-9. PubMed ID: 3517699
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acarbose and insulin dependent diabetes, type 1].
    Gabriel Botella F; Galindo Puerto MJ
    An Med Interna; 1996 Dec; 13(12):618. PubMed ID: 9063950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acarbose in the treatment of non-insulin-dependent diabetes mellitus; a new principle].
    Drent ML; van der Veen EA
    Ned Tijdschr Geneeskd; 1992 Feb; 136(7):308-10. PubMed ID: 1538796
    [No Abstract]   [Full Text] [Related]  

  • 19. [1-year study on the effect of guar on carbohydrate and lipid metabolism as well as tolerability in ambulatory glibenclamide-treated patients with diabetes mellitus].
    Klimm HD; Vollmar J; Bräuning C
    Beitr Infusionther Klin Ernahr; 1983; 12():206-15. PubMed ID: 6316912
    [No Abstract]   [Full Text] [Related]  

  • 20. Guar gum in hyperlipidemia.
    Ma CB; Hart LL
    DICP; 1990 May; 24(5):480-2. PubMed ID: 2188434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.